Ten Bay Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$11.5M
- Investors
-
2
Ten Bay Bio General Information
Description
Provider of biological therapies intended to address complex diseases in immunology. The company is currently operating in Stealth mode.
Contact Information
Formerly Known As
Reuleaux Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
- 4816 West Wisconsin Avenue
- Milwaukee, WI 53208
- United States
+1 (262)
Corporate Office
- 4816 West Wisconsin Avenue
- Milwaukee, WI 53208
- United States
+1 (262)
Ten Bay Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 12-May-2025 | $11.5M | Completed | Stealth |
Ten Bay Bio Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Clarevia Ventures | Venture Capital | Minority | ||
| Santé Ventures | Venture Capital | Minority |
Ten Bay Bio FAQs
-
When was Ten Bay Bio founded?
Ten Bay Bio was founded in 2024.
-
Where is Ten Bay Bio headquartered?
Ten Bay Bio is headquartered in Milwaukee, WI.
-
What industry is Ten Bay Bio in?
Ten Bay Bio’s primary industry is Clinics/Outpatient Services.
-
Is Ten Bay Bio a private or public company?
Ten Bay Bio is a Private company.
-
What is Ten Bay Bio’s current revenue?
The current revenue for Ten Bay Bio is .
-
How much funding has Ten Bay Bio raised over time?
Ten Bay Bio has raised $11.5M.
-
Who are Ten Bay Bio’s investors?
Clarevia Ventures and Santé Ventures have invested in Ten Bay Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process